These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5883470)

  • 1. Relationship of drug toxicity to chemotherapeutic effectiveness.
    Karrer K; Humphryes SR; Goldin A
    Antimicrob Agents Chemother (Bethesda); 1965; 5():539-43. PubMed ID: 5883470
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of microsomal enzyme modifiers on toxicity and therapeutic activity of cyclophosphamide in mice.
    Hart LG; Adamson RH
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):391-401. PubMed ID: 5348409
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.
    Rose WC; Trader MW; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 Sep; 62(9):1337-49. PubMed ID: 688277
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of chloramphenicol on the toxic and therapeutic actions of cyclophosphane].
    Bogush TA
    Antibiot Med Biotekhnol; 1986 Mar; 31(3):199-202. PubMed ID: 3717919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxicity of methotrexate and cyclophosphamide in mice inoculated with malignant neoplasms.
    Graczyk J
    Pol J Pharmacol Pharm; 1981; 33(1):73-80. PubMed ID: 7255281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W
    Acta Pol Pharm; 1992; 49(1-2):35-40. PubMed ID: 8769079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disulfiram (tetraethylthiuram disulfide) amd diethyldithiocarbamate on the bladder toxicity and antitumor activity of cyclophosphamide in mice.
    Hacker MP; Ershler WB; Newman RA; Gamelli RL
    Cancer Res; 1982 Nov; 42(11):4490-4. PubMed ID: 6290038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicology of anti-leukemic agents with special reference to phthalanilide derivatives.
    Kensler CJ; Palm PE; Day HM; Battista SP; Rogers WI; Yesair DW; Wodinsky I
    Cancer Res; 1965 Oct; 25(9):1622-37. PubMed ID: 5861081
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210).
    Canti G; Franco P; Marelli O; Ricci L; Nicolin A
    Cancer Res; 1984 Apr; 44(4):1551-6. PubMed ID: 6231100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of cancer cell kill by chemotherapeutic agents in vivo.
    Wilcox WS
    Natl Cancer Inst Monogr; 1967 Feb; 24():257-69. PubMed ID: 6021080
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synergistic effect of nucleoside and cyclophosphamide combination in murine L 1210 leukemia].
    Drings P; Osswald H
    Verh Dtsch Ges Inn Med; 1975; 81():1109-11. PubMed ID: 1229409
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN; Milushev AS; Todorov DK
    Neoplasma; 1980; 27(1):33-6. PubMed ID: 6892839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium iodide--doses it potentiate the activity of cyclophosphamide?
    Hart MM; Adamson RH
    Lancet; 1971 Jun; 1(7711):1243. PubMed ID: 4103105
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiosensitivity of drug-resistant L1210 leukemia.
    Johnson RE
    Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive values of the in vivo diffusion chamber for cyclophosphamide treatment of L1210 murine leukemia.
    Anderson KC; Humphrey RL; Sensenbrenner LL
    Cancer Res; 1983 May; 43(5):2030-3. PubMed ID: 6831434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of L1210 leukemia. II. Ultrastructural and cytochemical changes after treatment with cyclophosphamide and vitamin A.
    Brandes D; Anton E; Lam KW
    J Natl Cancer Inst; 1967 Sep; 39(3):385-421. PubMed ID: 6047994
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics of cyclophosphamide damage--sublethal damage repair and cell-cycle-related sensitivity.
    DeWys WD; Kight N
    Mod Hosp; 1969 Jan; 112(1):155-63. PubMed ID: 5773635
    [No Abstract]   [Full Text] [Related]  

  • 19. Circadian dependence of host and tumor responses to cyclophosphamide in mice.
    Cardoso SS; Avery T; Venditti JM; Goldin A
    Eur J Cancer (1965); 1978 Sep; 14(9):949-54. PubMed ID: 710487
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum.
    Scheving LE; Burns ER; Halberg F; Pauly JE
    Chronobiologia; 1980; 7(1):33-40. PubMed ID: 7192203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.